Andrew Rixon, OD, FAAO

Standardized glaucoma referral guidelines based on risk factors such as age, IOP and cup-to-disc ratio could improve care and efficiency, especially for patients aged 18 to 40 years, according to a study published in JAMA Network Open.

Healthy individuals with an induced transient increase in IOP experienced temporary axial elongation and subfoveal choroidal thinning, regardless of whether they had a refractive error, according to a study in Optometry and Vision Science.

Circumpapillary retinal nerve fiber layer and ganglion cell inner plexiform layer measurements may help predict visual field worsening in glaucoma, although each is more effective in different stages of disease, according to research.

Concurrent use of a beta-blocker with Simbrinza delayed the onset of ocular allergy and may extend treatment duration and adherence among patients with glaucoma, according to a retrospective study in BMC Ophthalmology.

While most children with glaucoma have at least one visual field test per year, Black and multiracial children were among those with significantly lower testing frequency, according to a single-center study published in Journal of Glaucoma.

Faster initial capillary density loss was associated with more rapid visual field progression and increased risk for event progression, prompting researchers to suggest the addition of OCT angiography for risk assessment in glaucoma.

Glaucoma appeared tied to significant costs not only for individuals, but also for society as a result of premature retirement and loss of productivity, according to a study conducted in Finland and published in PLOS One.

Individuals with glaucoma, age-related macular degeneration or cataract have a higher risk for both falls and fractures, according to research on a large cohort published in JAMA Ophthalmology.

The self-measurement iCare Home2 tonometer may be reliable for most eyes and clinical settings, although central corneal thickness measurements are recommended before use, according to research published in the Journal of Glaucoma.

Patients on systemic immunosuppressive therapy experienced diminished IOP reductions a year after receiving selective laser trabeculoplasty compared with those who were not immunosuppressed, according to a study.